TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
Life Sciences & Drug Development · Psychedelic medicines near approval, will transform mental health treatment
now playing · Life Sciences & Drug Development
Life Sciences & Drug Developmenttailwindscore 8/10christian angermayer
Psychedelic medicines near approval, will transform mental health treatment
Psilocybin and other psychedelics have near-zero downside when used medically with clinicians; first approvals expected early next year via presidential order, proving 1960s science works i…
Human Performance Enhancementtailwindscore 7/10christian angermayer
Enhanced Games proves medical PEDs aid athlete recovery, shifting moral debate
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games' clinical trial dataset will prove safety and effic…
Longevity & Agingtailwindscore 7/10christian angermayer
Hormone replacement therapy from 30s onward is key longevity intervention
Declining testosterone and estrogen drive aging symptoms; TRT and HRT starting in 30s/40s maintain youthful hormone levels, improving energy, cognition, and physical capacity. Angermayer pe…